Portable Affordable Innovative and Smart Device-Coupled Electronic Fetal Monitoring System to Improve Rural Access to Obstetrics Services and Improve Outcomes in Rural Communities
便携式经济实惠的创新智能设备耦合电子胎儿监护系统可改善农村地区获得产科服务的机会并改善农村社区的成果
基本信息
- 批准号:10382687
- 负责人:
- 金额:$ 102.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-23 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:3D PrintAddressAppointmentBiologicalCaringChargeClinicClinicalCodeCompanionsComputer softwareCountyCoupledDataData SetDevelopmentDevice DesignsDevicesDiabetes MellitusDiscipline of obstetricsEngineeringEnsureEvaluationFaceFetal MonitoringFetal healthFrequenciesFundingGelGynecologyHealth PersonnelHealthcareHigh-Risk PregnancyHomeHospitalsImprove AccessIn VitroInterventionLegal patentLifeLow incomeManikinsMaternal Health ServicesMeasurementMeasuresMedical DeviceMinorityMonitorMorbidity - disease rateMothersOutpatientsParticipantPatient CarePatientsPerformancePersonal SatisfactionPhasePregnancyPregnancy ComplicationsPregnant WomenPrenatal careProceduresResource-limited settingResourcesRiskRisk FactorsRuralRural CommunityRural MinoritySafetyServicesSignal TransductionSmall Business Technology Transfer ResearchStudy SubjectSurveysSystemTechnologyTestingTimeUnited States National Institutes of HealthUniversitiesUterine ContractionWomanbarrier to carebasebiomaterial compatibilityclinical decision-makingclinical practicecohortcommercializationcostcytotoxicitydata exchangedata sharingengineering designfetalhealth care availabilityhealth care qualityhuman subjectimprovedimproved outcomein vitro testinginfant outcomeinnovationminority communitiesmobile applicationmonitoring devicemortalitynovelobstetric careportabilitypregnantprogramsprototyperemote health careremote monitoringrural underservedsafety testingskin irritationtelehealthtelemonitoringunderserved communityusabilityvibration
项目摘要
PROJECT SUMMARY
To ensure fetal well-being, obstetricians monitor fetal heartrate (FHR) and uterine contractions on a weekly to
bi-weekly basis towards the end of pregnancy and during labor. Such monitoring is performed with an electronic
fetal monitor (EFM) to decrease the development of complications while minimizing the need for unnecessary
obstetric interventions. This is especially important for women with high-risk pregnancies. Inadequate monitoring
increases the risk of morbidity, mortality, and poor infant outcomes. Unfortunately, many women, especially in
rural and minority communities, face many barriers like sufficient time and resources to adequate prenatal care
like EFM. Furthermore, EFMs used in hospitals are not portable and can be prohibitively expensive for mid- to
low-resource communities. On the other hand, monitors for home use measure only 1 parameter and therefore
not approved for clinical decision making. Fetal Life’s solution is a novel EFM system based on a patent-pending
engineering design. Our innovation enables us to manufacture an EFM system as accurate as a hospital EFM,
but at a fraction of the cost, while maintaining a portable size with telemonitoring capabilities. Commercializing
this system will increase accessibility to necessary healthcare by reducing the cost and time required for prenatal
care for patients and healthcare providers.
In a successful Phase I program, Fetal Life met all Phase I milestones resulting in: 1) development of a prototype
of the system (devices plus patient-facing mobile app) and 2) confirmation that the system is usable by pregnant
patients and can detect contraction and FHR signals. Completion of the Phase I program was critical to
supporting the proposed Phase II program that will focus on completing and validating the EFM system with
telemonitoring capabilities for 510(k) clearance. Phase II efforts will include completing the system with the
addition of the healthcare provider-facing app and validating its accuracy with in vitro testing (Aim 1),
manufacturing and completing standard safety testing (Aim 2), and validating accuracy and usability of the
system in a statistically powered study with pregnant subjects (Aim 3). Successful completion of the Phase II
program will provide critical performance and safety data necessary for a 510(k) filing, and key data supporting
its use for telehealth, both of which are required for successful market deployment.
项目摘要
为了确保胎儿的健康,产科医生每周监测胎儿心率(FHR)和子宫收缩,
妊娠末期和分娩期间每两周一次。这种监测是用电子仪器进行的。
胎儿监护仪(EFM),以减少并发症的发展,同时尽量减少不必要的
产科干预。这对高危妊娠的妇女尤其重要。监测不足
增加发病率、死亡率和婴儿不良结局的风险。不幸的是,许多妇女,特别是在
农村和少数民族社区面临许多障碍,如足够的时间和资源,以充分的产前护理,
比如EFM此外,在医院中使用的EFM不是便携式的,并且对于中到老年人来说可能过于昂贵。
低资源社区。另一方面,家用监护仪仅测量1个参数,因此
未被批准用于临床决策。胎儿生命的解决方案是一种新颖的EFM系统的基础上,
工程设计我们的创新使我们能够制造出与医院EFM一样精确的EFM系统,
但成本只有一小部分,同时保持了具有远程监护能力的便携式尺寸。商业化
该系统将通过减少产前检查所需的费用和时间,
为患者和医疗保健提供者提供护理。
在一个成功的第一阶段计划,胎儿生活满足所有第一阶段的里程碑,导致:1)原型的发展
系统(设备加上面向患者的移动的应用程序)和2)确认系统可由孕妇使用
患者,并可以检测收缩和胎心率信号。第一阶段计划的完成对于
支持拟议的第二阶段计划,重点是完成和验证EFM系统,
510(k)许可的远程监控能力。第二阶段的工作将包括完成该系统,
增加面向医疗保健提供者的应用程序,并通过体外测试验证其准确性(目标1),
制造和完成标准安全测试(目标2),并验证
在妊娠受试者的统计学把握度研究中使用该系统(目标3)。成功完成第二阶段
该计划将提供510(k)申报所需的关键性能和安全性数据,以及支持
将其用于远程保健,这两者都是成功的市场部署所必需的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Swati Shah其他文献
Swati Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 102.2万 - 项目类别:
Research Grant